GCG and metabolic dysfunction-associated steatotic liver disease: Various drugs targeting liver metabolism are being investigated for NAFLD and steatohepatitis, including nuclear hormone receptor agonists, incretins, and sodium-glucose cotransporter inhibitors, which may improve both diabetic hyperglycemia and fatty liver disease[58].